BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Michael Ulz does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 SLNSilence Therapeutics PLC | Buy | $25.00 | May 2025 | +80.1% | Miss |
 VKTXViking Therapeutics Inc | Buy | $102.00 | Apr 2025 | +24.7% | Miss |
 CABACabaletta Bio Inc | Buy | $22.00 | Apr 2025 | +111.9% | Miss |
 KYTXKyverna Therapeutics, Inc. Common Stock | Buy | $20.00 | Apr 2025 | +303.7% | Miss |
 AARDAardvark Therapeutics, Inc. Common Stock | Buy | $29.00 | Mar 2025 | −51.1% | Miss |
| SLNSilence Therapeutics PLC | Buy | $45.00 | Mar 2025 | +11.1% | Miss |
 GUTSFractyl Health, Inc. Common Stock | Buy | $10.00 | Feb 2025 | −77.5% | Miss |
| SLNSilence Therapeutics PLC | Buy | $49.00 | Oct 2024 | −68.7% | Miss |
| SLNSilence Therapeutics PLC | Buy | $49.00 | Jun 2024 | −63.6% | Miss |
| KYTXKyverna Therapeutics, Inc. Common Stock | Buy | $40.00 | Mar 2024 | −94.4% | Miss |
| GUTSFractyl Health, Inc. Common Stock | Buy | $18.00 | Feb 2024 | −88.2% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.